DOWNGRADES
CNS Pharmaceuticals (CNSP)
Brokerage Firm: Ladenburg Thalmann | Action: Downgrade | Ratings Change: Buy » Neutral | Price Tgt: —
Ocular Therapeutix (OCUL)
Brokerage Firm: H.C. Wainwright | Action: Downgrade | Ratings Change: Buy » Neutral | Price Tgt: —
COVERAGE INITIATED
Amesite (AMST)
Brokerage Firm: The Benchmark Company | Action: Initiated | Ratings Change: Speculative Buy | Price Tgt: $7
Kinnate BioPharma (KNTE)
Brokerage Firm: Piper Sandler | Action: Initiated | Ratings Change: Overweight | Price Tgt: $60
Kinnate BioPharma (KNTE)
Brokerage Firm: Goldman | Action: Initiated | Ratings Change: Buy | Price Tgt: $48
Kinnate BioPharma (KNTE)
Brokerage Firm: SVB Leerink | Action: Initiated | Ratings Change: Outperform | Price Tgt: $52
Kinnate BioPharma (KNTE)
Brokerage Firm: Wedbush | Action: Initiated | Ratings Change: Outperform | Price Tgt: $48
PAE (PAE)
Brokerage Firm: Morgan Stanley | Action: Initiated | Ratings Change: Overweight | Price Tgt: $11
RMR Group (RMR)
Brokerage Firm: BTIG Research | Action: Initiated | Ratings Change: Buy | Price Tgt: $45
COVERAGE RESUMED
Amicus Therapeutics (FOLD)
Brokerage Firm: Cantor Fitzgerald | Action: Resumed | Ratings Change: Overweight | Price Tgt: $20 » $30
Autolus Therapeutics (AUTL)
Brokerage Firm: H.C. Wainwright | Action: Resumed | Ratings Change: Buy | Price Tgt: $19
REITERATED/PRICE TARGET CHANGED
Anaplan (PLAN)
Brokerage Firm: Needham | Action: Reiterated | Ratings Change: Buy | Price Tgt: $85 » $95
Elastic (ESTC)
Brokerage Firm: Monness Crespi & Hardt | Action: Reiterated | Ratings Change: Buy | Price Tgt: $156 » $184
Fathom Holdings (FTHM)
Brokerage Firm: ROTH Capital | Action: Reiterated | Ratings Change: Buy | Price Tgt: $28 » $40
Power Integrations (POWI)
Brokerage Firm: Cowen | Action: Reiterated | Ratings Change: Outperform | Price Tgt: $72 » $90